By Benjamin Chiou
Date: Wednesday 24 Apr 2024
(Sharecast News) - The chief financial officer of consumer health company Haleon is to step down after three years and will be replaced by Tate & Lyle's CFO Dawn Allen.
Holding(s) in Company | 25-Apr-2024 | 15:45 | RNS |
Directorate Change | 24-Apr-2024 | 07:00 | RNS |
Director/PDMR Shareholding | 22-Apr-2024 | 14:30 | RNS |
Holding(s) in Company | 19-Apr-2024 | 10:15 | RNS |
Holding(s) in Company | 17-Apr-2024 | 16:15 | RNS |
Questor : Tate & Lyle | 02-Jun-2011 | Telegraph |
Questor :Tate & Lyle | 03-Feb-2011 | Telegraph |
Investment Column : Tate & Lyle | 05-Nov-2010 | The Independent |
Questor: Tate & Lyle | 09-Nov-2009 | Sunday Telegraph |
FTSE latest: BA, RBS up; Rentokil down | 06-Nov-2009 | Daily Mail |
No recent information was found.
Currency | UK Pounds |
Share Price | 632.50p |
Change Today | -1.50p |
% Change | -0.24 % |
52 Week High | 831.50 |
52 Week Low | 591.00 |
Volume | 146,224 |
Shares Issued | 401.69m |
Market Cap | £2,540.72m |
RiskGrade | 93 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 3 |
Neutral | 2 |
Sell | 0 |
Strong Sell | 0 |
Total | 9 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 23-Nov-23 | 22-Jun-23 |
Paid | 05-Jan-24 | 02-Aug-23 |
Amount | 6.20p | 13.10p |
Time | Volume / Share Price |
15:49 | 1 @ 633.50p |
15:48 | 37 @ 633.50p |
15:48 | 3 @ 632.50p |
15:47 | 5 @ 633.50p |
15:47 | 1 @ 633.50p |
CEO | Nick Hampton |
CFO | Dawn Allen |
Chair | David Hearn |
You are here: research